Xerosis Treatment Market Report 2026

Xerosis Treatment Market Overview

• Xerosis Treatment market size has reached to $9.4 billion in 2025 • Expected to grow to $12.12 billion in 2030 at a compound annual growth rate (CAGR) of 5.2% • Growth Driver: Rising Healthcare Expenditure Fueling The Growth Of The Market Due To Enhanced Access To Advanced Dermatological Care • Market Trend: Bayer Launches Bepanthen In India To Combat Widespread Dry Skin With Advanced Hydration Technology • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Xerosis Treatment Market?

Xerosis treatment focuses on restoring moisture to the skin and repairing the skin barrier to relieve dryness, flaking, and discomfort. This typically involves the use of emollients and moisturizers that help hydrate the skin and prevent further water loss. Gentle skin care practices, such as using mild, fragrance-free cleansers and avoiding hot water or harsh scrubbing, are also important. The main type of xerosis treatment includes medication and personal care products. Medication refers to substances or compounds used to diagnose, treat, prevent, or manage diseases or medical conditions in individuals. These are available in various forms that include tablets, lotion, cream, ointment, shower forms, and others. It is used for various symptoms, including roughness, tightness, itching, and flaky skin, by various end users, such as hospitals, clinics, home care settings, and others.

What Is The Xerosis Treatment Market Growth Forecast?

The xerosis treatment market size is expected to see strong growth in the next few years. It will grow to $12.12 billion in 2030 at a compound annual growth rate (CAGR) of 5.2%. The growth in the forecast period can be attributed to development of innovative emollients and humectants, expansion of dermatology and homecare settings, rising geriatric and pediatric population, increasing adoption of multi-symptom care products, integration of digital skincare monitoring solutions. Major trends in the forecast period include rising demand for moisturizers and emollients, growth in at-home skincare treatments, increasing awareness about skin hydration and care, expansion of fragrance-free and sensitive skin products, integration of multi-symptom relief products.

Global Xerosis Treatment Market Segmentation

1) By Type: Medication, Personal Care Products 2) By Form: Tablets, Lotion, Cream, Ointment, Shower Forms, Other Forms 3) By Symptoms: Roughness, Tightness, Itching, Flaky Skin 4) By End Users: Hospitals, Clinics, Homecare Settings, Other End Users Subsegments: 1) By Medication: Topical Corticosteroids, Oral Antihistamines, Immunomodulators, Antibacterial Agents, Antifungal Agents 2) By Personal Care Products: Moisturizers, Emollients, Humectants, Bath Additives, Cleansers

What Are The Drivers Of The Xerosis Treatment Market?

The increasing healthcare expenditure is projected to fuel the growth of the xerosis treatment market going forward. Healthcare expenditure refers to the total amount of resources spent on health services, including prevention, diagnosis, treatment, and management of diseases, by individuals, governments, and organizations. Advancements in medical technology are driving up healthcare expenditure, as newer diagnostic tools and treatments often come with higher costs for development, implementation, and ongoing patient care. Increasing healthcare expenditure enhances access to dermatological care, enabling early diagnosis and consistent management of xerosis through professional guidance and advanced treatment options. For instance, in May 2024, according to the Office for National Statistics, a UK-based government agency, total healthcare spending rose by 5.6% in 2023, while long-term health and social care expenditure grew by 2.8% in real terms in 2022. Therefore, the increasing healthcare expenditure is driving the growth of the xerosis treatment industry. The increased prevalence of chronic skin conditions is expected to propel the growth of the xerosis treatment market going forward. Chronic skin conditions are long-lasting dermatological disorders that persist for months or even years, often requiring ongoing management and causing symptoms like itching, inflammation, or skin lesions. The prevalence of chronic skin conditions is increasing primarily due to rising exposure to environmental pollutants, which trigger inflammation and weaken the skin’s natural barrier. Xerosis treatment helps manage chronic skin conditions by restoring skin hydration and strengthening the skin barrier, reducing dryness and irritation while improving overall skin health. For instance, in 2023, according to the American Academy of Dermatology, a US-based non-profit organization, acne is the most common skin condition in the United States, affecting up to 50 million Americans annually. Therefore, the increased prevalence of chronic skin conditions is driving the growth of the xerosis treatment industry.

Key Players In The Global Xerosis Treatment Market

Major companies operating in the xerosis treatment market are Pfizer Inc., The Procter & Gamble Company, Johnson & Johnson, Unilever PLC, Bayer AG, Sanofi S.A., L’Oréal S.A., GlaxoSmithKline plc, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Galderma S.A., Dr. Reddy’s Laboratories Ltd., LEO Pharma A/S, Arcutis Biotherapeutics Inc., Neutrogena, Aveeno, CeraVe, La Roche-Posay, Nivea, Cetaphil.

Global Xerosis Treatment Market Trends and Insights

Major companies operating in the xerosis treatment market are focusing on developing technological advancements, such as dexpanthenol, to enhance skin hydration and repair. Dexpanthenol is a derivative of pantothenic acid (vitamin B5) that helps in moisturizing and repairing the skin. It penetrates the skin easily and promotes healing and regeneration. For instance, in October 2024, Bayer, a Germany-based domestic pharmaceutical and biotechnology company, launched Bepanthen in India, which aims to enhance skin hydration and promote healing of dry or damaged skin. Bayer’s launch of Bepanthen in India highlighted its focus on addressing widespread dry skin, affecting nearly half of the population. The product is designed to provide deep hydration, support skin barrier repair, and promote natural skin regeneration, making it suitable for daily skincare needs.

Regional Outlook

North America was the largest region in the xerosis treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Xerosis Treatment Market?

The xerosis treatment market consists of sales of cleansing bars, body oils and barrier repair creams. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.